USE OF ROXITHROMYCIN (ESPAROXY®) IN THE TREATMENT OF UROGENITAL CHLAMYDIOSIS
- Authors: Pronkin E.A1
-
Affiliations:
- Issue: No 3 (2016)
- Pages: 92-96
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/288691
- ID: 288691
Cite item
Open Access
Access granted
Abstract
Urogenital chlamydiosis is a common sexually transmitted infection. The steady increase in detection of chlamydiosis is due not only to the introduction of a wide screening, but also a large number of self-medication patients, that leads to more severe forms of the disease. The article considers the possibility of use of roxithromycin for the treatment of chlamydial (non-gonococcal) urethritis in men. Foreign and domestic clinical studies confirm the efficacy and safety of roxithromycin (Esparoxy).
Full Text
About the authors
E. A Pronkin
Email: dr.pronkin@gmail.com
PhD, Associate Professor at the Department of Urology SBEI HPE RNSMU n.a. N.I. Pirogov of RMPH Moscow
References
- Эйдельштейн И.А. Фундаментальные изменения в классификации хламидий и родственных им микроорганизмов порядка Chlamydiales. Клинич. микробиол. и антимикроб, химиотер. 1999;1(1):5-11.
- Кубанова А.А. Анализ эпидемиологической ситуации и динамика заболеваемости инфекциями, передаваемыми половым путем, и дерматозами на территории Российской Федерации. Вестник дерматол. и венерол. 2010;5:4-21.
- Скрипки Ю.К, Самсонов В.А., Селисский Г.Д., Гомберг М.А. Современные проблемы дерматовенерологии. Вестник дерматол. и венерол. 1997;6:4-8.
- Cates W.Jr,. Rolfs R.T.Jr., Aral S.O. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol. Rev. 199;12:199-220.
- CDC. Family planning methods and practice: Africa. 2nd ed. Atlanta (GA): United States Department of Health and Human Services, CDC. 1999.
- Скибицкий В.А. Роль медико-социальных, эпидемиологических и конституциональнопсихологических факторов в формировании групп риска по инфекциям, передаваемым половым путем, среди подростков. Дисс. канд. мед. наук. Новосибирск, 2000.
- Sonnenberg P., Clifton S., Beddows S., Field N., Soldan K., Tanton C., Mercer C.H., da Silva F.C., Alexander S., Copas A.J., Phelps A., et al. Risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382 (9907):1795-806.
- Jacobson D.L., Peralta L., Graham N.M., Zenilman J. Histologic development of cervical ectopy: relationship toreproductive hormones. Sex. Transm. Dis. 2000;27:252-8.
- Quinn T.C., Gaydos C., Shepherd M., Bobo L., Hook E.W. 3rd, Viscidi R., Rompalo A. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA. 1996;276:1737-42.
- Российское общество дерматовенерологов и косметологов. Федеральные клинические рекомендации по ведению больных хламидийной инфекцией. 2015.
- Анисимова Н.С. Организация системы эпидемиологического наблюдения за хламидийной инфекцией. Дисс. канд. мед. наук. М., 2014. C.5.
- Кубанова А.А. Ведение больных с инфекциями, передаваемыми половым путем и урогенитальными инфекциями. Клинические рекомендации. 2013. 91 с.
- Odenholt-Tornqvist I., Löwdin E., Cars O. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. Antimicrob. Agents Chemother. 1995;39(1):221-26.
- Grimble A., Csonka G.W. Skin testing in 246 patients with non-specificurethritis with a review of the important literature. Br. J. Vener. Dis. 1955;31(4):228-34.
- Samra Z., Rosenberg S., Kaufman L. Antibiotic susceptibility of Urea- plasma urealyticum. The 2 nd International Conference on the Macrolides, Azalides and Streptogramins. Venice. 1994;Abstr. 146.
- Козлова В.И., Пухнер А.Ф. Вирусные, хламидийные и микоплазменные заболевания гениталий. М., 1997;10-11, 46-47, 341 с.
- Кисина В.И., Ковалык В.П. Инфекции мочеполовых органов у женщин. О тактике ведения больных воспалительными заболеваниями мочеполовых органов. Consilium Medicum. 2004;6:472-76.
- Samra Z., Rosenberg S., Soffer Y., Dan M. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracy- clines. Diagn. Microbiol. Infect. Dis. 2001;39(3):177-79.
- Ridgway G.L. A review of the in vitro activity of roxithromycin againstgenital pathogens. J. Antimicrob. Chemother. 1987; 20(Suppl. B):7-11.
- Lidbrink P., Bygdeman S., Emtestam L. Roxithromycin compared to doxycycline in the treatment of genital chlamydial infection and non-specific urethritis. Int. J. STD. AIDS. 1993;4(2):110-13.
- Markham A., Faulds D. Roxithromycin. An update of its antimicro-bial activity, pharmacokinetic properties and therapeutic use. Drugs. 1994;48(2):297-326.
- Van der Willigen A.H., Tjiam K.H. Evaluation of roxithromycin in the treatment of non-gonococcal urethritis in males. Eur. J. Clin. Microbiol. 1986;5(6):612-14.
- Lassus A., Seppala A. Roxithromycin in nongonococcal urethritis. J Antimicrob. Chemother. 1987;20(Suppl. B):157-65.
- Van Schouwenburg J., de Bruyn O., Fourie E., et al. A randomized, comparative study of the efficacy and tolerance of roxithromycin and doxycycline in the treatment of women with positive endocervical cultures for Chlamydia trachomatis and Mycoplasma spp. in an in vitro fertilization program. Diagn. Microbiol. Infect. Dis. 1992;15(Suppl. 4):129-31.
- Lidbrink P., Bygdeman S., Emtestam L., Gajecki M., Lapins J., Weden U. Roxithromycin compared to doxycycline in the treatment of genital chlamydial infection and non-specific urethritis. Int. J. STD. AIDS. 1993;4:110-13.
- Radowicki S., Tyc M., Kulesza E., Dowgiallo-Smolarczyk J. Roxithromycin (Rulid) in treatment of Chlamydia trachomatis genital infec tions in women. Ginekol. Pol.1995;66:354-56.
- Worm A.M. Roxithromycin and erythromycin in chlamydia-negative non-gonococcal urethritis. Acta. Derm. Venereol. 1990;70:269-71.
Supplementary files
